Antibiotic Management in Bronchiectasis - 27/02/22
Doi : 10.1016/j.ccm.2021.11.009
Charles S. Haworth, MBChB, MD a, b, ⁎ 
, Roderigo Andres Floto, MBBCh, PhD a, c
, Roderigo Andres Floto, MBBCh, PhD a, c a Cambridge Centre for Lung Infection, Royal Papworth Hospital, Cambridge CB2 0AY, UK
b Department of Medicine, University of Cambridge, Cambridge, UK
c University of Cambridge Molecular Immunity Unit, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK
∗Corresponding author. Cambridge Centre for Lung Infection, Royal Papworth Hospital, Cambridge CB2 0AY, UK.Cambridge Centre for Lung InfectionRoyal Papworth HospitalCambridgeCB2 0AYUK
Resumen |
Antibiotics are an essential component of the management of patients with bronchiectasis. This article reviews the role of antibiotics in the treatment of exacerbations, for maintenance therapy to reduce exacerbation frequency, and for eradicating potentially harmful organisms such as Pseudomonas aeruginosa.
El texto completo de este artículo está disponible en PDF.Keywords : Bronchiectasis, Antibiotics, Intravenous, Nebulized, Oral, Exacerbation, Chronic suppressive, Eradication
Esquema
Crown Copyright © 2021
Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 43 - N° 1
P. 165-177 - mars 2022 Regresar al número
Artículo precedente
- Airway Clearance and Mucoactive Therapies in Bronchiectasis
- Anne E. O’Donnell
- Future Directions in Bronchiectasis Research
- Rosanel Amaro, Lídia Perea, Oriol Sibila
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?